Tag: Biotech and Pharma

UK drugmaker AstraZeneca overcame a drop in sales in China and the arrest of its top executive in the country to deliver an 18 per cent increase in revenues in the final quarter of 2024.

Bristol Myers Squibb on Thursday said it will slash $2 billion in costs by the end of 2027, expanding its ongoing cost savings effort to chart a path toward long-term growth.

Eli Lilly forecast annual profit largely above Wall Street estimates on Thursday, providing some relief to investors after another quarter of sales miss for its popular diabetes and weight-loss treatments.

GSK plans to buy back $2.50 billion in shares and raised its midterm sales target, citing promising pipeline developments.

Danish drugmaker Novo Nordisk on Wednesday posted another quarter of rapid profit growth, though the story for once wasn’t its wildly popular weight-loss drugs.

Shares of vaccine companies fell on Tuesday after a Senate panel voted to advance Robert F. Kennedy Jr.’s nomination to lead the Department of Health and Human Services to the full chamber. 

Merck said it will pause shipments of Gardasil to China through at least mid-year, as continued weak demand for the HPV vaccine there is expected to hurt 2025 revenue, but it still posted a strong fourth-quarter profit on sales of cancer drug Keytruda.

Drugmaker Pfizer posted a better than expected fourth quarter profit on Thursday, helped by cost cuts and a smaller-than-feared drop in sales of its COVID-19 vaccine.

AstraZeneca turned down an offer of nearly £80mn in UK state support when it abruptly cancelled plans for a £450mn vaccine manufacturing site near Liverpool, according to people briefed on the matter.

Shares of Vertex Pharmaceuticals Inc. surged ahead of Friday’s market open after the Food and Drug Administration approved the company’s non-opioid pain treatment.

Novo Nordisk announced positive trial results for its next-generation obesity drug, leading to a 7.13% surge in its share price on Friday.

Shares of Novo Nordisk jumped Friday after the Danish pharmaceutical giant reported positive early-stage results for its once weekly amycretin obesity drug.

Πολύ σημαντική χαρακτηρίζει η διοίκηση της Lavipharm την υπογραφή της στρατηγικής εμπορικής συμφωνίας που ανακοίνωσε η πολυεθνική φαρμακευτική εταιρεία iNova Pharmaceuticals, ιδιοκτήτρια, μεταξύ άλλων, του brand Betadine.

Johnson & Johnson’s stock reversed gains made early Wednesday immediately after earnings were released, after the medical technology and drug company beat estimates for the fourth quarter, but offered some mixed guidance.

Moderna cut its 2025 sales forecast by $1 billion on Monday, hurt by a slow adoption of its respiratory syncytial virus (RSV) shot and weak demand for COVID-19 vaccines, sending its shares down more than 18% in premarket trading.

China has detected the new mutated strain of the mpox virus for the first time, as the pathogen spreads to more geographies after the World Health Organization declared the outbreak in Africa a new global health emergency last year.

Το τίμημα της εξαγοράς περιλαμβάνει σταθερό ποσό ύψους 1,5 εκατ. ευρώ και μεταβλητό, το οποίο θα καθοριστεί με βάση τα μελλοντικά οικονομικά μεγέθη της εταιρείας.

Shares of Danish pharmaceutical giant Novo Nordisk plummeted more than 24% at one point on Friday after reporting results in a late-stage trial for its experimental CagriSema weight loss drug that missed expectations.

Merck on Wednesday said it has snagged the rights to an experimental weight loss pill from Chinese drugmaker Hansoh Pharma, in a deal worth up to $2 billion.

Shares of Pfizer  were rising in premarket trading Tuesday after the drug company released financial guidance for 2025 that roughly lined up with Wall Street expectations.